Company intelligence
Altoida, Inc.
Pioneering digital #biomarkers of neurological disease using augmented reality and machine learning.
About Altoida, Inc.
Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster and more sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine.
Verified activity
Signals from Altoida, Inc.
2 published signals
Research & Knowledge
Altoida, Inc. announced the launch of the Altoida Digital NeuroMarker Platform, designed to capture real-time multimodal data through ten minutes on a tablet leveraging augmented reality.
Reported by Altoida, Inc.
Research & Knowledge
Altoida, Inc. published a paper in the European Journal of Neurology titled 'EAN’s leadership in bringing together neurologists and trainees, computer scientists, ethicists, regulatory experts and patient representatives is exactly what this moment requires'
Reported by Altoida, Inc.